Insiders · Profile

Townson Sharon

Chief Scientific Officer at Monte Rosa Therapeutics. Filing since 5 Jan 2026. CIK 0001855689

Company
Date
Role
Action
Shares
Amount
Of holding
6 Jul 2026
Chief Scientific Officer
Sold on a plan
6,000
$139.85K
8.1%
23 Jun 2026
Chief Scientific Officer
Sold on a plan
3,000
$60.00K
4.2%
17 Jun 2026
Chief Scientific Officer
Sold on a plan
3,000
$57.00K
4.2%
29 May 2026
Chief Scientific Officer
Sold on a plan
6,000
$119.22K
8.1%
5 Jan 2026
Chief Scientific Officer
Sold at will
3,155
$47.86K
4.4%
5 decisions on file.